Literature DB >> 3813680

Desensitisation to allopurinol.

S M Kelsey, G R Struthers, T Beswick, D R Blake.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3813680      PMCID： PMC1002064          DOI： 10.1136/ard.46.1.84

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Desensitisation in a patient with chronic renal disease and severe allergy to allopurinol.

Authors:  A Meyrier
Journal:  Br Med J       Date:  1976-08-21

2.  Allopurinol hypersensitivity in a patient with severe, chronic, tophaceous gout.

Authors:  E Webster; R S Panush
Journal:  Arthritis Rheum       Date:  1985-06

3.  Reinstitution of allopurinol therapy for gouty arthritis after cutaneous reactions.

Authors:  A G Fam; T W Paton; A Chaiton
Journal:  Can Med Assoc J       Date:  1980-07-19       Impact factor: 8.262

4.  Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.

Authors:  D E Bax; R S Amos
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103
  4 in total
  4 in total

1.  Desensitisation to allopurinol.

Authors:  M G Ridley; J A Mathews
Journal:  Ann Rheum Dis       Date:  1987-11       Impact factor: 19.103

2.  Alternatives to allopurinol.

Authors:  A S Jawad
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

3.  Sulphasalazine desensitisation in patients with arthritis.

Authors:  C McCarthy; R Coughlan
Journal:  Ir J Med Sci       Date:  1994-05       Impact factor: 1.568

Review 4.  Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.

Authors:  A G Fam
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.686
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.